此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Prospective Italian Validation of SMS in Patients With Suspected Acute Stroke (PIVA-SMS)

2026年5月15日 更新者:Frisullo Giovanni、Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Prospective Italian Multicenter Study for the Validation of the Stroke Mimics Score (SMS) in Patients With Suspected Acute Stroke

The overall objective of the study is to prospectively validate the diagnostic accuracy of the Stroke Mimics Score (SMS). This score is calculated using information collected at the time of the patient's arrival in the Emergency Department (triage) and may assist clinicians in distinguishing between:

  1. cerebrovascular events (ischemic stroke, intracerebral hemorrhage, and transient ischemic attack [TIA]),
  2. stroke mimics (i.e., conditions that present with stroke-like symptoms but without actual infarction of brain tissue).

In addition, the study aims to compare its results with other existing tools and to evaluate its performance across different patient groups.

Specifically, the present research seeks to generate data on the reliability of the SMS tool in providing an accurate diagnosis.

研究概览

研究类型

观察性的

注册 (估计的)

1000

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

  • 成人
  • 年长者

接受健康志愿者

不

取样方法

非概率样本

研究人群

Adult patients presenting to the Emergency Department with suspected acute stroke during the enrollment period.

The final discharge diagnosis will serve as the gold standard.

描述

Inclusion Criteria:

  • Age ≥ 18 years at the time of presentation to the Emergency Department.
  • Presentation to the Emergency Department with a clinical suspicion of acute stroke, identified at nursing triage and/or through activation of the stroke pathway.
  • Presentation to the Emergency Department during the 6-month prospective enrollment period.
  • Feasibility of real-time collection of the data required to calculate the Stroke Mimics Score (SMS), including:

age, systolic blood pressure, presence/absence of seizure at onset, presence/absence of headache at onset, presence/absence of confusion at onset, presence/absence of syncope at onset, presence/absence of isolated sensory deficit, presence/absence of motor deficit, history of coronary artery disease, history of prior stroke or transient ischemic attack (TIA).

  • Availability of a final hospital discharge diagnosis at the end of hospitalization or Emergency Department observation.
  • Signed informed consent from the patient or caregiver. If the patient is unconscious upon arrival at the Emergency Department, deferred consent will be applied.

Exclusion Criteria:

  • Age < 18 years.
  • Inability to fully collect the data required to calculate the Stroke Mimics Score (SMS).
  • Absence of a clearly defined final hospital discharge diagnosis.
  • Voluntary discharge, transfer, or death before completion of the diagnostic workup, in the absence of a reliable diagnosis.
  • Repeated Emergency Department visits for the same clinical event (only the first visit will be considered).

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
The rate of accuracy of Stroke Mimics Score (SMS)
大体时间:through study completion, about 1 year

Diagnostic accuracy of the Stroke Mimics Score (SMS) in discriminating between:

  1. cerebrovascular events (CVE),
  2. stroke mimics (SM),

assessed by:

Area Under the Receiver Operating Characteristic Curve (AUROC). The AUROC will be calculated with a 95% confidence interval. An AUROC value significantly higher than 0.70 will be considered indicative of an acceptable discriminative ability of the score.

through study completion, about 1 year

次要结果测量

结果测量
措施说明
大体时间
Analyses across clinical subgroups
大体时间:through study completion, about 1 year
To evaluate sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), score calibration, the performance of the grouped version (SMSg), comparison with FABS and TMS, and analyses across clinical subgroups.
through study completion, about 1 year

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Giovanni Frisullo、Fondazione Policlinico Universitario Agostino Gemelli IRCCS

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (估计的)

2026年6月1日

初级完成 (估计的)

2026年12月1日

研究完成 (估计的)

2027年6月1日

研究注册日期

首次提交

2026年5月6日

首先提交符合 QC 标准的

2026年5月15日

首次发布 (实际的)

2026年5月22日

研究记录更新

最后更新发布 (实际的)

2026年5月22日

上次提交的符合 QC 标准的更新

2026年5月15日

最后验证

2026年5月1日

更多信息

与本研究相关的术语

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅